Results 11 to 20 of about 1,110,432 (191)

The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity

open access: yesFrontiers in Immunology, 2018
Interleukin-33 (IL-33) is a IL-1 family member of cytokines exerting pleiotropic activities. In the steady-state, IL-33 is expressed in the nucleus of epithelial, endothelial, and fibroblast-like cells acting as a nuclear protein.
Claudia Afferni   +11 more
doaj   +1 more source

Bacteriological and Immunological study of kidney failure patients infected with urinary tract infections [PDF]

open access: yesE3S Web of Conferences, 2023
Urinary tract infections (UTIs) are one of the most common medical conditions in women and men. They are caused by bacteria that enter the urinary tract through the urethra or the skin around the genitals.
Mhana Shahrabanawah Mahdi Yasin   +1 more
doaj   +1 more source

IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline [PDF]

open access: yes, 2016
Alzheimer’s disease (AD) is a devastating condition with no known effective treatment. AD is characterized by memory loss as well as impaired locomotor ability, reasoning, and judgment.
Chan, Ivy C. W.   +10 more
core   +1 more source

The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD

open access: yesRespiratory Research, 2018
Background Interleukin(IL)-33 is an epithelial alarmin important for eosinophil maturation, activation and survival. The aim of this study was to examine the association between IL-33, its receptor expression and airway eosinophilic inflammation in non ...
Damian Tworek   +8 more
doaj   +1 more source

IL-33/sST2 axis in The Cardiovascular System: A Brief Review [PDF]

open access: yesTrends in Pharmaceutical Sciences, 2020
IL-33 is a type of cytokine and a new member of the IL-1 family labeled as an alarmin, which is released under stressful settings. IL-33 is a biomechanically induced protein and is mainly produced by cardiac fibroblasts and is expressed by various cell ...
Negar Firouzabadi, Maryam Dashti
doaj   +1 more source

Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. [PDF]

open access: yes, 2016
Group 2 innate lymphoid cells (ILC2s) and type 2 helper T cells (Th2 cells) are the primary source of interleukin 5 (IL-5) and IL-13 during type 2 (allergic) inflammation in the lung.
Austen, K Frank   +5 more
core   +1 more source

Association of IL-33, IL1RL1 gene polymorphisms with serum IL-33 levels and risk of asthma in adults and asthmatic bronchitis in children (Chinese)

open access: yesBiotechnology & Biotechnological Equipment, 2018
IL-33 binding to IL1RL1 is involved in asthma. The data show that involvement of the IL33/IL1RL1 genes in asthma is biologically plausible. The objective of this study was to investigate the association of IL33 and IL1R1 gene polymorphisms and serum IL ...
Guangyang Zhang   +4 more
doaj   +1 more source

Structural Basis of IL-1 Family Cytokine Signaling

open access: yesFrontiers in Immunology, 2019
Interleukin-1 (IL-1) family cytokines are key signaling molecules in both the innate and adaptive immune systems, mediating inflammation in response to a wide range of stimuli.
James K. Fields   +6 more
doaj   +1 more source

IL-33 in Rheumatic Diseases

open access: yesFrontiers in Medicine, 2021
Interleukin-33 (IL-33) is a nuclear factor mainly expressed in barrier epithelium, endothelial cells, and fibroblast reticular cells. Some inflammatory cells also express IL-33 under certain conditions.
Yuanji Dong, Jixin Zhong, Lingli Dong
doaj   +1 more source

Serum sST2 levels predict severe exacerbation of asthma

open access: yesRespiratory Research, 2018
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We hypothesized that high serum sST2 levels in stable asthmatics are a predictor for
Masato Watanabe   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy